MBX Biosciences, Inc. (MBX) — Stock Score Summary

MBX Biosciences, Inc. (MBX) has a MoatMap StockRank of 42/100 based on Quality (45/100), Value (38/100), and Momentum (46/100) factor scores. The current signal is HOLD. Insufficient information to identify a clear asymmetric opportunity driven by the specified macro themes, and the quantitative quality score (Q:44) is too low for a quality compounder.

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for rare endocrine diseases with high unmet medical needs. The company's competitive moat lies in its specialized focus on these underserved patient populations and its proprietary drug development platform designed to address complex hormonal imbalances. MBX aims to secure orphan drug designations, potentially leading to expedited development pathways and market exclusivity for its novel treatments.

Key Financial Metrics

Price$31.90
Market Cap$1.5B
P/E (Forward)-8.05
Price/Book3.45
Return on Equity-25.7%
Return on Invested Capital-26.5%
Debt/Equity0.13
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-52M

MBX Biosciences, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is MBX Biosciences, Inc.’s (MBX) StockRank?
MoatMap’s StockRank for MBX Biosciences, Inc. (MBX) is 42/100, with a Hold signal. It is a composite of Quality (45), Value (38), and Momentum (46) factor ranks across MoatMap’s 19,000+ stock universe.
Does MBX Biosciences, Inc. have an economic moat?
MBX Biosciences, Inc. (MBX) has a Quality factor score of 45/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is MBX Biosciences, Inc. a buy, hold, or sell?
MoatMap’s current signal for MBX Biosciences, Inc. (MBX) is Hold, based on a StockRank of 42/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is MBX Biosciences, Inc. in?
MBX Biosciences, Inc. (MBX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksMBX deep dive reportAI ChampionsHow we score stocksSense-check another stock